Cargando…
Personalization of cancer treatment using predictive simulation
BACKGROUND: The personalization of cancer treatments implies the reconsideration of a one-size-fits-all paradigm. This move has spawned increased use of next generation sequencing to understand mutations and copy number aberrations in cancer cells. Initial personalization successes have been primari...
Autores principales: | Doudican, Nicole A, Kumar, Ansu, Singh, Neeraj Kumar, Nair, Prashant R, Lala, Deepak A, Basu, Kabya, Talawdekar, Anay A, Sultana, Zeba, Tiwari, Krishna Kumar, Tyagi, Anuj, Abbasi, Taher, Vali, Shireen, Vij, Ravi, Fiala, Mark, King, Justin, Perle, MaryAnn, Mazumder, Amitabha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320499/ https://www.ncbi.nlm.nih.gov/pubmed/25638213 http://dx.doi.org/10.1186/s12967-015-0399-y |
Ejemplares similares
-
Predictive Simulation Approach for Designing Cancer Therapeutic Regimens with Novel Biological Mechanisms
por: Doudican, Nicole A., et al.
Publicado: (2014) -
Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines
por: Kobayashi, Susumu S., et al.
Publicado: (2016) -
In silico modeling predicts drug sensitivity of patient-derived cancer cells
por: Pingle, Sandeep C, et al.
Publicado: (2014) -
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study
por: Drusbosky, Leylah M., et al.
Publicado: (2019) -
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)